Helixmith Co Ltd banner
H

Helixmith Co Ltd
KOSDAQ:084990

Watchlist Manager
Helixmith Co Ltd
KOSDAQ:084990
Watchlist
Price: 9 410 KRW -0.63% Market Closed
Market Cap: ₩433.7B

Helixmith Co Ltd
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Helixmith Co Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
H
Helixmith Co Ltd
KOSDAQ:084990
Total Current Liabilities
₩5.1B
CAGR 3-Years
-47%
CAGR 5-Years
-46%
CAGR 10-Years
15%
Celltrion Inc
KRX:068270
Total Current Liabilities
₩4.5T
CAGR 3-Years
51%
CAGR 5-Years
33%
CAGR 10-Years
21%
O
OliX Pharmaceuticals Inc
KOSDAQ:226950
Total Current Liabilities
₩21.3B
CAGR 3-Years
-19%
CAGR 5-Years
37%
CAGR 10-Years
N/A
V
Voronoi Inc
KOSDAQ:310210
Total Current Liabilities
₩6.8B
CAGR 3-Years
-28%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Total Current Liabilities
₩239.7B
CAGR 3-Years
36%
CAGR 5-Years
62%
CAGR 10-Years
89%
A
ABL Bio Inc
KOSDAQ:298380
Total Current Liabilities
₩123.5B
CAGR 3-Years
20%
CAGR 5-Years
73%
CAGR 10-Years
N/A
No Stocks Found

Helixmith Co Ltd
Glance View

Market Cap
433.7B KRW
Industry
Biotechnology

Helixmith Co., Ltd. engages in the development and sale of bio and natural substances. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-29. The firm operates its business through two segments. The Natural Products Business segment develops and sells raw materials for functional materials and health functional foods such as Alex, Murphine, and Nimosin. The New Biopharmaceutical Business segment develops diabetic neuropathy treatment, diabetic ischemic foot ulcer, amyotrophic lateral sclerosis treatment, ischemic heart disease, and anticancer treatment.

Intrinsic Value
2 261.56 KRW
Overvaluation 76%
Intrinsic Value
Price ₩9 410
H

See Also

What is Helixmith Co Ltd's Total Current Liabilities?
Total Current Liabilities
5.1B KRW

Based on the financial report for Sep 30, 2025, Helixmith Co Ltd's Total Current Liabilities amounts to 5.1B KRW.

What is Helixmith Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
15%

Over the last year, the Total Current Liabilities growth was -10%. The average annual Total Current Liabilities growth rates for Helixmith Co Ltd have been -47% over the past three years , -46% over the past five years , and 15% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett